Novel aspects of the insulin-like growth factor binding proteins

Molecular Genetics and Metabolism

Volumn 68, Issue 2, 1999, Pages 161-181

  Wetterau, Lawrence A ^a   Moore, Michael G ^a   Lee, Kuk Wah ^a   Shim, Melanie L ^a   Cohen, Pinchas ^a  

^a MATTEL CHILDREN S HOSPITAL   (United States)

Author keywords

Apoptosis; Cancer; IGF independent; Insulin like growth factor binding protein related proteins; Insulin like growth factor binding proteins; Insulin like growth factors

Indexed keywords

CATHEPSIN; KALLIKREIN; MATRIX METALLOPROTEINASE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN BINDING PROTEIN 6;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CELL GROWTH; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG ACTIVITY; FEMALE; GROWTH REGULATION; HUMAN; LUNG CANCER; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; SHORT SURVEY;

EID: 0032736408     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.1999.2920     Document Type: Article

References (235)

1. Baxter R C. Insulin-like growth factor binding proteins in the human circulation, a review. Horm Res. 42:1994;140-144.
2. Twigg S M, Baxter R C. Insulin-like growth factor (IGF)-binding protein-5 forms an alternative ternary complex with IGFs and the acid-labile subunit. J Biol Chem. 273:1998;6074-6079.
3. Khosravi M J, Diamandi A, Mistry J, Krishna R G, Khare A. Acid-labile subunit of human insulin-like growth factor-binding protein complex: Measurement, molecular, and clinical evaluation [comment in J Clin Endocrinol Metab82:3941-3943, 1997]. J Clin Endocrinol Metab. 82:1997;3944-3951.
4. Hasegawa T, Cohen P, Rosenfeld R G. Characterization of the insulin-like growth factor axis in TM 3 Leydig cells. Growth Regul. 5:1995;151-159.
5. Cohen P, Rosenfeld R G. The IGF axis. Rosenbloom A L. Human Growth Hormone, Basic and Scientific Aspects. 1995;43-58 CRC Press, Boca Raton.
6. Arany E, Afford S, Strain A J, Winwood P J, Arthur M J, Hill D J. Differential cellular synthesis of insulin-like growth factor binding protein 1 and IGFBP-3 within human liver. J Clin Endocrinol Metab. 79:1994;1871-1876.
7. Chin E, Zhou J, Dai J, Baxter R C, Bondy C A. Cellular localization and regulation of gene expression for components of the insulin-like growth factor ternary binding protein complex. Endocrinology. 134:1994;2498-2504.
8. Villafuerte B C, Koop B L, Pao C I, Gu L, Birdsong G G, Phillips L S. Coculture of primary rat hepatocytes and nonparenchymal cells permits expression of insulin-like growth factor binding protein-3 in vitro. Endocrinology. 134:1994;2044-2050.
9. Rosenfeld R G, Pham H, Cohen P, Fielder P, Gargosky S E, Müller H, Nonoshita L, Oh Y. Insulin-like growth factor binding proteins and their regulation. Acta Paediatr. 339:1994;154-158.
10. Baxter R C, Binoux M A, Clemmons D R, Conover C A, Drop S L, Holly J M, Mohan S, Oh Y, Rosenfeld R G. Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology. 139:1998;4036.
11. Cohen P, Fielder P J, Hasegawa Y, Frisch H, Giudice L C, Rosenfeld R G. Clinical aspects of insulin-like growth factor binding proteins. Acta Endocrinol. 124:1991;74-85.
12. Holly J MP, Martin J L. IGFBPs: A review of methodological aspects of their purification, analysis and regulation. Growth Regul. 4:1994;20-30.
13. Lamson G, Giudice L C, Rosenfeld R G. Insulin-like growth factor binding proteins: Structural and molecular relationships. Growth Factors. 5:1991;19-28.
14. Underwood L E, Thissen J P, Lemozy S, Ketelslegers J M, Clemmons D R. Hormonal and nutritional regulation of IGF-I and its binding proteins. Hormone Res. 42:1994;145-151.
15. Katz L EL, Rosenfeld R G, Cohen P. Clinical significance of insulin-like growth factor binding proteins (IGFBPs). Endocrinologist. 5:1995;36-43.
16. Smith W J, Underwood L E, Clemmons D R. Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab. 80:1995;443-449.
17. Baxter R C, Saunders H. Radioimmunoassay of insulin-like growth factor-binding protein-6 in human serum and other body fluids. J Endocrinol. 134:1992;133-139.
18. Mohan S, Farley J R, Baylink D J. Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: Implications for bone loss with aging. Prog Growth Factor Res. 6:1995;465-473.
19. Mohan S, Libanati C, Dony C, Lang K, Srinivasan N, Baylink D J. Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metab. 80:1995;2638-2645.
20. Thoren M, Hilding A, Brismar T, Magnusson P, Degerblad M, Larsson L, Saaf M, Baynick D, Mohan S. Serum levels of insulin-like growth factor binding proteins (IGFBP)-4 and -5 correlate with bone mineral density in growth hormone (GH)-deficient adults and increase with GH replacement therapy. J Bone Miner Res. 13:1998;891-899.
21. Shimasaki S, Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5, and -6). Prog Growth Factor Res. 3:1991;243-266.
22. Hong Y S, Kim S Y, Bhattacharya A, Pratt D R, Hong W K, Tainsky M A. Structure and function of the HOX A1 human homeobox gene cDNA. Gene. 159:1995;209-214.
23. Matsui T, Hirai M, Hirano M, Kurosawa Y. The HOX complex neighbored by the EVX gene, as well as two other homeobox-containing genes, the GBX-class and the EN-class, are located on the same chromosomes 2 and 7 in humans. FEBS Lett. 336:1993;107-110.
24. Allander S V, Bajalica S, Larsson C, Luthman H, Powell D R, Stern I, Weber G, Zazzi H, Ehrenborg E. Structure and chromosomal localization of human insulin-like growth factor-binding protein genes. Growth Regul. 3:1993;3-5.
25. Ruoslathi E, Pierschlaber M D. New perspectives in cell adhesions: RGD and integrins. Science. 238:1987;491-497.
26. Coverley J A, Baxter R C. Phosphorylation of insulin-like growth factor binding proteins. Mol Cell Endocrinol. 128:1997;1-5.
27. Levitt Katz L E, Satin-Smith M S, Collett-Solberg P, Thornton P S, Baker L, Stanley C A, Cohen P. Insulin-like growth factor binding protein-1 levels in the diagnosis of hypoglycemia caused by hyperinsulinism [comment in: J Pediatr131:171-173, 1997]. J Pediatr. 131:1997;193-199.
28. Counts D R, Gwirtsman H, Carlsson L M, Lesem M, Cutler G B Jr. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. J Clin Endocrinol Metab. 75:1992;762-767.
29. Strasser-Vogel B, Blum W F, Past R, Kessler U, Hoeflich A, Meiler B, Kiess W. Insulin-like growth factor (IGF)-I and -II and IGF-binding proteins-1, -2, and -3 in children and adolescents with diabetes mellitus: Correlation with metabolic control and height attainment. J Clin Endocrinol Metab. 80:1995;1207-1213.
30. Unterman T G, Oehler D T, Murphy L J, Lacson R G. Multihormonal regulation of insulin-like growth factor-binding protein-1 in rat H4IIE hepatoma cells: The dominant role of insulin. Endocrinology. 128:1991;2693-2701.
31. Argente J, Caballo N, Barrios V, Munoz M T, Pozo J, Chowen J A, Hernandez M. Disturbances in the growth hormone-insulin-like growth factor axis in children and adolescents with different eating disorders. Horm Res. 48:1997;16-18.
32. Conover C A, Divertie G D, Lee P D. Cortisol increases plasma insulin-like growth factor binding protein-1 in humans. Acta Endocrinol. 128:1993;140-143.
33. Lee P DK, Conover C A, Powell D R. Regulation and function of insulin-like growth factor binding protein-1. Proc Soc Exp Biol Med. 204:1993;4-29.
34. Price W A, Stiles A D, Moats-Staats B M, D'Ercole A J. Gene expression of insulin-like growth factors (IGFs), the type I IGF receptor, and the IGF-binding proteins in dexamethasone-induced fetal growth retardation. Endocrinology. 130:1992;1424-1432.
35. Conover, C, A, Lee, P, D, Riggs, B, L, Powell, D, R. Insulin-like growth factor binding protein-1 expression in cultured human bone cells: Regulation by insulin and glucocorticoids. Endocrinology137:3295-3301.
36. Samstein B, Hoimes M L, Fan J, Frost R A, Gelato M C, Lang C H. IL-6 stimulation of insulin-like growth factors binding proteins (IGFBPs) production. Biochem Biophys Res Commun. 228:1996;611-615.
37. Murphy, L, J, Rajkumar, K, Molnar, P. Phenotypic manifestations of insulin-like growth factor binding protein-1 (IGFBP-1) and IGFBP-3 overexpression in transgenic mice. Prog Growth Factor Res6:425-432.
38. Gutierrez-Ospina G, Calikoglu A S, Ye P, D'Ercole A J. In vivo effects of insulin-like growth factor-I on the development of sensory pathways: Analysis of the primary somatic sensory cortex (S1) of transgenic mice. Endocrinology. 137:1996;5484-5492.
39. Russo V C, Bach L A, Fosang A J, Baker N L, Werther G A. Insulin-like growth factor binding protein-2 binds to cell surface proteoglycans in the rat brain olfactory bulb. Endocrinology. 138:1997;4858-4867.
40. Arai T, Busby W Jr, Clemmons D R. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology. 137:1996;4571-4575.
41. Schwander J, Mary J L. The RIA for IGFBP-2 in man: A meagre catch. Growth Regul. 3:1993;104-108.
42. Bernardini S, Cianfarani S, Spagnoli A, Annicchiarico-Petruzzelli M, Melino G, Massoud R, Boscherini B, Finazzi-Agro A, Rosenfeld R G, Federici G. Expression and down-regulation by retinoic acid of IGF binding protein-2 and -4 in medium from human neuroblastoma cells. J Neuroendocrinol. 6:1994;409-413.
43. Muller H L, Oh Y, Lehrnbecher T, Blum W F, Rosenfeld R G. Insulin-like growth factor binding protein-2 concentrations in cerebrospinal fluid and serum of children with malignant solid tumors or acute leukemia. J Clin Endocrinol Metab. 79:1994;428-434.
44. Walter H, Berry M, Hill D, Cwyfan-Hughes S, Holly J. Distinct sites of insulin-like growth factor (IGF)-II expression and localization in lesioned rat brain: Possible roles of IGF binding proteins (IGFBPs) in the mediation of IGF-II activity. Endocrinology. 140:1999;520-532.
45. Chambery D, de Galle B, Babajko S. Retinoic acid stimulates IGF binding protein (IGFBP)-6 and depresses IGFBP-2 and IGFBP-4 in SK-N-SH human neuroblastoma cells. J Endocrinol. 159:1998;227-232.
46. Foll J, Dannecker L, Zehrer C, Hettmer S, Berger J, Elminger M, Niethammer D, Ranke M B, Dannecker G E. Activation-dependent expression of the insulin-like growth factor binding protein-2 in human lymphocytes. Immunology. 94:1998;173-180.
47. Katz L, Bhala A, Camron E, Nunn S E, Hintz R L. IGF-II, IGF-binding proteins and IGF receptors in pancreatic β-cell lines. J Endocrinol. 152:1997;455-464.
48. Hardouin S, Gurmelem M, Noguiez P, Seurin D, Roghani M, Le Bouc Y, Povoa G, Merimee T J, Hossenlopp P, Binoux M. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: Relationship with growth hormone and IGFs and physiologic significance. J Clin Endocrinol Metab. 69:1989;1291-1301.
49. Kelley K M, Oh Y, Gargosky S E, Gucef Z, Matsumoto T, Hwa I, Ng L, Simpson D M, Rosenfeld R G. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Intern J Biochem Cell Biol. 28:1996;619-637.
50. Smith W J, Underwood L E, Clemmons D R. Effects of caloric or protein restriction on the insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. J Clin Endocrinol Metab. 80:1995;443-449.
51. Paolisso G, Ammendola S, Del Buono A, Gambardella A, Riondino M, Tagliamonte M R, Rizzo M R, Carella C, Varricchio M. Serum levels of insulin-like growth factor-I (IGF-I) and IGF-binding protein-3 in healthy centenarians: Relationship with plasma leptin and lipid concentrations, insulin action, and cognitive function. J Clin Endocrinol Metab. 82:1997;2204-2209.
52. Conover C A, Clarkson J T, Bale L K. Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts. Endocrinology. 136:1995;1403-1410.
53. Gucev Z S, Oh Y, Kelley K M, Labarta J I, Vorwerk P, Rosenfeld R G. Evidence for insulin-like growth factor (IGF)-independent transcriptional regulation of IGF binding protein-3 by growth hormone in SKHEP-1 human hepatocarcinoma cells. Endocrinology. 138:1997;1464-1470.
54. Vaccarello M A, Diamond F B Jr, Guevara-Aguirre J, Rosenbloom A L, Fielder P J, Gargosky S, Cohen P, Wilson K, Rosenfeld R G. Hormonal and metabolic effects and pharmacokinetics of recombinant insulin-like growth factor-I in growth hormone receptor deficiency/Laron syndrome. J Clin Endocrinol Metab. 77:1993;273-280.
55. Kanety H, Karasik A, Klinger B, Silbergeld A, Laron Z. Long-term treatment of Laron type dwarfs with insulin-like growth factor-1 increases serum insulin-like growth factor-binding protein-3 in the absence of growth hormone activity. Acta Endocrinol. 128:1993;144-149.
56. Zapf J, Hauri C, Waldvogel M, Futo E, Hasler H, Binz K, Guler H P, Schmid C, Froesch E R. Recombinant human insulin-like growth factor I induces its own specific carrier protein in hypophysectomized and diabetic rats. Proc Natl Acad Sci USA. 86:1989;3813-3817.
57. Lemmey A B, Glassford J, Flick-Smith H C, Holly J M, Pell J M. Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I. J Endocrinol. 154:1997;319-328.
58. Conover C A, Clarkson J T, Durham S K, Bale L K. Cellular actions of insulin-like growth factor binding protein-3. LeRoith D, Raizada M K. Current Directions in Insulin-like Growth Factor Research. 1994;255-265 Plenum Press, New York.
59. Kanzaki S, Baxter R C, Knutsen R, Baylink D J, Mohan S. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions. J Bone Miner Res. 10:1995;854-858.
60. Olney R C, Wilson D M, Mohtai M, Fielder P J, Smith R L. Interleukin-1 and tumor necrosis factor-alpha increase insulin-like growth factor-binding protein-3 (IGFBP-3) production and IGFBP-3 protease activity in human articular chondrocytes. J Endocrinol. 146:1995;279-286.
61. Besset V, Le Magueresse-Battistoni B, Collette J, Benahmed M. Tumor necrosis factor alpha stimulates insulin-like growth factor binding protein 3 expression in cultured porcine Sertoli cells. Endocrinology. 137:1996;296-303.
62. Oh Y, Müller H L, Ng L, Rosenfeld R G. Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem. 270:1995;13589-13592.
63. Han G R, Dohi D F, Lee H Y, Rajah R, Walsh G L, Hong W K, Cohen P, Kurie J M. All-trans-retinoic acid increases transforming growth factor-beta2 and insulin-like growth factor binding protein-3 expression through a retinoicacid receptor-alpha-dependent signaling pathway. J Biol Chem. 272:1997;13711-13716.
64. Hayden J M, Strong D D, Baylink D J, Powell D R, Sampath T K, Mohan S. Osteogenic protein-1 stimulates production of insulin-like growth factor binding protein-3 nuclear transcripts in human osteosarcoma cells. Endocrinology. 138:1997;4240-4247.
65. Smith E P, Dickson B A, Chernausek S D. Insulin-like growth factor binding protein-3 secretion from cultured rat sertoli cells: Dual regulation by follicle stimulating hormone and IGF-1. Endocrinology. 127:1990;2744-2751.
66. Huynh H, Yang Y F, Pollak M. Estradiol and antiestrogens regulate a growth inhibitory insulin-like growth factor binding protein 3 autocrine loop in human breast cancer cells. J Biol Chem. 271:1996;1016-1021.
67. DiBattista J A, Dore S, Morin N, Abribat T. Prostaglandin E2 up-regulates insulin-like growth factor binding protein-3 expression and synthesis in human articular chondrocytes by a c-AMP-independent pathway: Role of calcium and protein kinase A and C. J Cell Biochem. 63:1996;320-333.
68. Agarwal C, Lambert A, Chandraratna R AS, Rorke E A, Eckert R L. Vitmain D regulates human ectocervical epithelial cell proliferation and insulin-like growth factor-binding protein-3 level. Biol Reprod. 60:1999;567-572.
69. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger B R, Kley N. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature. 377:1995;646-649.
70. Jaques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu R T, Havemann K. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology. 138:1997;1767-1770.
71. Noll K, Wegmann B, Havemann K, Jaques G. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines. J Clin Endocrinol Metab. 81:1996;2653-2662.
72. Li W, Fawcett J, Widmer H R, Fielder P J, Rabkin R, Keller G A. Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. Endocrinology. 138:1997;1763-1766.
73. Schedlich L J, Young T F, Firth S M, Baxter R C. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem. 273:1998;18347-18352.
74. Wraight C J, Liepe I J, Werther G A. Intranuclear localization of insulin-like growth factor binding protein-3 during cell division in human keratinocytes. J Invest Dermatol. 111:1998;239-242.
75. Murphy L J, Molnar P, Lu X, Huang H. Expression of human insulin-like growth factor-binding protein-3 in transgenic mice. J Mol Endocrinol. 15:1995;293-303.
76. Nickerson T, Pollak M, Huynh H. Castration-induced apoptosis in the rat ventral prostate is associated with increased expression of genes encoding insulin-like growth factor binding proteins 2, 3, 4, and 5. Endocrinology. 139:1998;807-810.
77. Oh Y, Müller H L, Lamson G, Rosenfeld R G. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. J Biol Chem. 268:1993;14964-14971.
78. Rees C, Clemmons D R, Horvitz G D, Clarkes J B, Busby W H. A protease-resistant form of insulin-like growth factor (IGF) binding protein 4 inhibits IGF-1 actions. Endocrinology. 139:1998;4182-4188.
79. Lawrence J B, Oxvig C, Overgaard M T, Sottrup-Jensen L, Gleich G J, Hays L G, Yates J R, Conover C A. The insulin-like growth factor binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA. 96:1999;3149-3153.
80. Kelly K M, Oh Y, Gargosky S E, Gucev Z, Matsumoto T, Hwa V, Ng L, Simpson D M, Rosenfeld R G. Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol. 28:1996;619-637.
81. Wang J, Niu W, Witte D P, Chernausek S D, Nikiforox Y E, Clemens T L, Sharifi B, Strauch A R, Fagin J A. Overexpression of insulin-like growth factor-binding protein-4 (IGFBP-4) in smooth muscle cells of transgenic mice through a smooth muscle alpha-actin-IGFBP-4 fusion gene induces smooth muscle hypoplasia. Endocrinology. 139:1998;2605-2614.
82. Damon S E, Maddison L, Ware J L, Plymate S R. Overexpression of an inhibitory insulin-like growth factor binding protein (IGFBP), IGFBP-4, delays onset of prostate tumor formation. Endocrinology. 139:1998;3456-3464.
83. Mason H D, Cwyfan-Hughes S, Molly J MP, Franks S. Potent inhibition of human ovarian steroidogenesis by insulin-like growth factor binding protein-4 (IGFBP-4). J Clin Endocrinol Metab. 83:1998;284-287.
84. Damon S E, Hauck K L, Birnbaum R S, Quinn L S. Retrovirally mediated overexpression of IGFBP-4: Evidence that insulin-like growth factor is required for skeletal muscle differentiation. J Cell Phys. 175:1998;109-120.
85. Ewton D Z, Coolican S A, Mohan S, Chernausek S D, Florini J R. Modulation of insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: A dual role for IGFBP-5. J Cell Phys. 177:1998;47-57.
86. Mohan S, Nakao Y, Honda Y, Landale E, Leser U, Dony C, Lang K, Baylink D J. Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells. J Biol Chem. 270:1995;20424-20431.
87. Scharla S H, Strong D D, Mohan S, Baylink D J, Linkhart T A. 1,25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology. 129:1991;3139-3146.
88. Mohan S, Farley J R, Baylink D J. Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: Implications for bone loss with aging. Prog Growth Factor Res. 6:1995;465-473.
89. Mohan S, Libanati C, Dony C, Lang K, Srinivasan N, Baylink D J. Development, validation, and application of a radioimmunoassay for insulin-like growth factor binding protein-5 in human serum and other biological fluids. J Clin Endocrinol Metab. 80:1995;2638-2645.
90. Booth B A, Boes M, Andress D L, Dake B L, Kiefer M C, Maack C, Linhart R J, Bar K, Caldwell E E, Weiler J. IGFBP-3 and IGFBP-5 association with endothelial cells: Role of C-terminal heparin binding domain. Growth Regul. 5:1995;1-17.
91. Jones J I, Gockerman A, Busby W H Jr, Camacho-Hubner C, Clemmons D R. Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I. J Cell Biol. 121:1993;679-687.
92. Andress D L, Birnbaum R S. Human osteoblast-derived insulin-like growth factor (IGF) binding protein-5 stimulates osteoblast mitogenesis and potentiates IGF action. J Biol Chem. 267:1992;22467-22472.
93. Clemmons D R. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytol Growth Factor Rev. 8:1997;45-62.
94. Canalis E, Gabbitas B. Skeletal growth factors regulate the synthesis of insulin-like factor binding protein-5 in bone cell cultures. J Biol Chem. 270:1995;10771-10776.
95. Conover C A, Bale L K, Clarkson J T, Torring O. Regulation of insulin-like growth factor binding protein-5 messenger ribonucleic acid expression and protein availability in rat osteoblast-like cells. Endocrinology. 132:1993;2525-2530.
96. Gabbitas B, Canalis E. Insulin-like growth factors sustain insulin-like growth factor-binding protein-5 expression in osteoblasts. Am J Physiol. 275:1998;E222-E228.
97. Conover C A, Clarkson J T, Bale L K. Effect of glucocorticoid on insulin-like growth factor (IGF) regulation of IGF-binding protein expression in fibroblasts. Endocrinology. 136:1995;1403-1410.
98. Okazaki R, Riggs B L, Conover C A. Glucocorticoid regulation of insulin-like growth factor binding protein expression in normal human osteoblast-like cells. Endocrinology. 134:1994;126-132.
99. Duan C, Hawes S B, Prevette T, Clemmons D R. Insulin-like growth factor-I (IGF-I) regulates IGF-binding protein-5 synthesis through transcriptional activation of the gene in aortic smooth muscle cells. J Biol Chem. 271:1996;4280-4288.
100. Duan C, Clemmons D. Differential expression and biological effects of insulin-like growth factor-binding protein-4 and -5 in vascular smooth muscle cells. J Biol Chem. 273:1998;16836-16842.
101. Bach L A, Thotakura N R, Rechler M M. Human insulin-like growth factor-binding protein-6 is O-glycosylated. Growth Regul. 3:1993;59-62.
102. Claussen M, Buergisser D, Schuller A G, Matzner U, Braulke T. Regulation of insulin-like growth factor (IGF)-binding protein-6 and mannose 6-phosphate/IGF-II receptor expression in IGF-II over expressing NIH 3T3 cells. Mol Endocrinol. 9:1995;902-912.
103. Bach L A. Insulin-like growth factor binding protein-6: The forgotten binding protein. Horm Metab Res. 31:1999;226-234.
104. Bach L A, Hsieh S, Brown A L. Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II induced differentiation of L6A1 myoblasts. Endocrinology. 135:1994;2168-2176.
105. Bach L A, Salemi R, Leeding K S. Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II induced proliferation and differentiation of L6A1 rat myoblasts. Endocrinology. 136:1995;5061-5069.
106. Sheikh M S, Shao Z M, Hussain A, Clemmons D R, Chen J C, Roberts C T Jr, LeRoith D, Fontana J A. Regulation of insulin-like growth factor binding protein-1, 2, 3, 4, 5, and 6: Synthesis, secretion, and gene expression in estrogen receptor-negative human breast carcinoma cells. J Cell Physiol. 155:1993;556-567.
107. Zhou Y, Mohan S, Linkhart T A, Baylink D J, Strong D D. Retinoic acid regulates insulin-like growth factor-binding protein expression in human osteoblast cells. Endocrinology. 137:1996;975-983.
108. Hossenlopp P, Segovia B, Lassare C, Roghani M, Bredon M, Binoux M. Enzymatic evidence of degradation of insulin-like growth factor binding protein in 150 k complex during pregnancy. J Clin Endocrinol Metab. 71:1990;797-805.
109. Cohen P, Graves H C, Peehl D M, Kamarei M, Giudice L C, Rosenfeld R G. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab. 75:1992;1046-1053.
110. Rajah R, Bhala A, Nunn S E, Peehl D M, Cohen P. 7S nerve growth factor is an insulin-like growth factor binding protein protease. Endocrinology. 137:1996;2676-2682.
111. Conover C, DeLeon D D. Acid activated insulin-like growth factor binding protein-3 proteolysis in normal and transformed cells. J Biol Chem. 2691:1994;7076-7080.
112. Conover C, Perry J, Tindall D. Endogenous cathepsin-D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells. J Clin Endocrinol Metab. 80:1995;987-993.
113. Nunn S, Peehl D M, Cohen P. Acid-activated insulin-like growth factor binding protein protease activity of cathepsin D in normal and malignant prostatic epithelial cells and seminal plasma. J Cell Physiol. 171:1997;196-204.
114. Claussen M, Kubler B, Wendland M, Neifer K, Schmidt B, Zapf J, Braulke T. Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology. 138:1997;3797-3803.
115. Fowlkes J L, Suzuki K, Nagase H, Thrailkill K M. Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: A role for matrix metalloproteinases. Endocrinology. 135:1994;2810-2813.
116. Fowlkes J L, Enghild J J, Suzuki K, Nagase H. Matrix metalloproteinases degrade insulin-like growth factor binding protein-3 in dermal fibroblast cultures. J Biol Chem. 269:1994;742-746.
117. Rajah R, Katz L, Nunn S, Solberg P, Beers T, Cohen P. Insulin-like growth factor binding protein proteases: Functional regulators of cell growth. Prog Growth Factor Res. 6:1996;273-284.
118. Angelloz-Nicoud P, Harel L, Binoux M. Recombinant human insulin-like growth factor (IGF) binding protein-3 stimulates prostate carcinoma cell proliferation via an IGF-dependent mechanism. Growth Regul. 6:1996;130-136.
119. Zheng B, Clarke J B, Busby W H, Duan C, Clemmons D R. Insulin-like growth factor-binding protein-5 is cleaved by physiological concentrations of thrombin. Endocrinology. 139:1998;1708-1714.
120. Bereket A, Wilson T A, Kolasa A J, Fan J, Lang C H. Regulation of the insulin-like growth factor system by acute acidosis. Endocrinology. 137:1996;2238-2245.
121. Nunn S, Beers Gibson T, Rajah R, Cohen P. Regulation of prostate cell growth by the insulin-like growth factor binding proteins and their proteases. Endocrine. 7:1997;115-118.
122. Cohen P, Noveral J P, Bhala A, Nunn S E, Herrick D J, Grunstein M M. Leukotriene D4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis. Am J Physiol. 269:1995;L151-157.
123. Rajah R, Nunn S, Herrick D, Grunstein M, Cohen P. LTD-4 induces matrix metalloproteinase-1 which functions as an IGFBP protease in airway smooth muscle cells. Am J Physiol. 271:1996;L1014-1022.
124. Wu H, Lee C, Rechler M. Proteolysis of insulin-like growth factor binding protein-3 in serum from pregnant, non-pregnant and fetal rats by matrix melloproteinases and serine proteases. Horm Metab Res. 31:1999;186-191.
125. Cohen P, Peehl D M, Graves H C, Rosenfeld R G. Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol. 142:1994;407-415.
126. Blat C, Villaudy J, Binoux M. In vivo proteolysis of serum IGFBP-3 results in increased availability of IGF to target cells. J Clin Invest. 93:1994;2286-2290.
127. Besnard N, Pisselet C, Zapf J, Hornebeck W, Monniaux D, Monget P. Proteolytic activity is involved in changes in intrafollicular insulin-like growth factor binding protein levels during growth and atresia of ovine ovarian follicles. Endocrinology. 137:1996;1599-1607.
128. Rajah R, Nachajon R, Collins M, Hakonarson H, Grunstein M, Cohen P. Elevated levels of IGF-binding protein protease in asthmatic airway smooth muscle. Am J Respir Cell Mol Biol. 20:1999;199-208.
129. Manes S, Llorente M, Lacalle R, Gomez-Mouton C, Kremer L, Mira E, Martinez-A C. The matrix metalloproteinase-9 regulates the insulin-like growth factor-triggered autocrine response in DU-145 carcinoma cells. J Biol Chem. 274:1999;6935-6945.
130. Bereket A, Lang C H, Blethen S L, Fan J, Frost R A, Wilson T A. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab. 80:1995;2282-2288.
131. Fowlkes J L, Thrailkill K M, George-Nascimento C, Rosenberg C K, Serra D M. Heparin-binding, highly basic regions within the thyroglobulin type-1 repeat of insulin-like growth factor (IGF)-binding proteins (IGFBPs)-3, -5, and -6 inhibit IGFBP-4 degradation. Endocrinology. 138:1997;2280-2285.
132. Donnelly M J, Holly J M. The role of IGFBP-3 in the regulation of IGFBP-4 proteolysis. J Endocrinol. 149:1996;R1-R7.
133. Salahifar H, Baxter R C, Martin J L. Insulin-like growth factor binding protein (IGFBP)-3 protease activity secreted by MCF-7 breast cancer cells: Inhibition by IGFs does not require IGF-IGFBP interaction. Endocrinology. 138:1997;1683-1690.
134. Clemmons D R, Gardner L I. A plasma factor is required for IGFBP-1 to potentiate DNA synthesis. J Cell Physiol. 145:1990;129-135.
135. Elgin R G, Busby W H, Clemmons D R. An insulin-like growth factor binding protein enhances the biologic response to IGF-I. Proc Natl Acad Sci USA. 84:1997;3254-3258.
136. Koistinen R, Itkonen O, Selenius P, Seppala M. Insulin-like growth factor-binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis. Biochem Biophys Res Commun. 173:1990;408-415.
137. Clemmons D R, Cascieri M A, Camacho-Hubner C, McCusker R H, Bayne M L. Discrete alterations of the insulin-like growth factor I molecule which alter its affinity for insulin-like growth factor-binding proteins result in changes in bioactivity. J Biol Chem. 265:1990;12210-12216.
138. Jones J I, Gockerman A, Busby W H Jr, Wright G, Clemmons D R. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA. 90:1993;10553-10557.
139. Galiano R D, Zhao L L, Clemmons D R, Roth S I, Lin X, Mustoe T A. Interaction between the IGF family and the integrin receptor family in tissue repair processes. J Clin Invest. 98:1996;2462-2468.
140. Tsuboi R, Shi C M, Sato C, Cox G N, Ogawa H. Co-administration of insulin-like growth factor (IGF)-I and IGF-binding protein-1 stimulates wound healing in animal models. J Invest Dermatol. 104:1995;199-203.
141. Jyung R W, Mustoe J A, Busby W H, Clemmons D R. Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1. Surgery. 115:1994;133-139.
142. Clemmons D R. Role of post translational modifications in modifying the biologic activity of insulin like growth factor binding proteins. LeRoith D, Raizada M K. Current Directions in Insulin-like Growth Factor Research. 1994;245-253 Plenum Press, New York.
143. Lewitt M S, Saunders H, Cooney G J, Baxter R C. Effect of human insulin-like growth factor-binding protein-1 on the half-life and action of administered insulin-like growth factor-I in rats. J Endocrinol. 136:1993;253-260.
144. Bar R S, Boes M, Clemmons D R, Busby W H, Sandra A, Dake B L, Booth B A. Insulin differentially alters transcapillary movement of intravascular IGFBP-1, IGFBP-2 and endothelial cell IGF-binding proteins in the rat heart. Endocrinology. 127:1990;497-499.
145. DeMellow J SM, Baxter R C. Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGF-I stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun. 156:1998;199-204.
146. Conover C A, Powell D R. Insulin-like growth factor (IGF)-binding protein-3 blocks IGF-I-induced receptor down-regulation and cell desensitization in cultured bovine fibroblasts. Endocrinology. 129:1991;710-716.
147. Hamon G A, Hunt T K, Spencer E M. In vivo effects of systemic insulin-like growth-I alone and complexed with insulin-like growth factor binding protein-3 on corticosteroid suppressed wounds. Growth Regul. 3:1993;55-56.
148. Clark R G, Mortensen D, Reifsynder D, Mohler M, Etcheverry T, Mukku V. Recombinant human insulin-like growth factor binding protein-3 (rhIGFBP-3): Effects on the glycemic and growth promoting activities of rhIGF-1 in the rat. Growth Regul. 3:1993;50-52.
149. Weinzimer, S, A, Macarak, E, Cohen, P, The role of the IGF-IGFBP axis in the regulation of bladder smooth muscle growth. Manuscript in preparation.
150. Li Y M, Schacher D H, Liu Q, Arkins S, Rebeiz N, McCusker R H Jr, Dantzer R, Kelley K W. Regulation of myeloid growth and differentiation by the insulin-like growth factor I receptor. Endocrinology. 138:1997;362-368.
151. Karas M, Danilenko M, Fishman D, LeRoith D, Levy J, Sharoni Y.
152. Olney R C, Tsuchiya K, Wilson D M, Mohtai M, Maloney W J, Schurman D J, Smith R L. Chondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but not IGF-II or IGFBP-4. J Clin Endocrinol Metab. 81:1996;1096-1103.
153. Barreca A, Artini P G, Cesarone A, Arvigo M, D'Ambrogio G, Genazzani A R, Giordano G, Minuto F. Interrelationships between follicle stimulating hormone and the growth hormone - insulin-like growth factor - IGF-binding proteins axes in human granulosa cells in culture. J Endocrinol Invest. 19:1996;35-42.
154. de la Sota R L, Simmen F A, Diaz T, Thatcher W W. Insulin-like growth factor system in bovine first-wave dominant and subordinate follicles. Biol Reprod. 55:1996;803-812.
155. Hasegawa Y, Hasegawa T, Fujii K, Konii H, Anzo M, Aso T, Koto S, Takada M, Tsuchiya Y. High ratios of free to total insulin-like growth factor-I in early infancy. J Clin Endocrinol Metab. 82:1997;156-158.
156. Powell D R. Effects of renal failure on the growth hormone-insulin-like growth factor axis. J Pediatr. 131:1997;S13-S16.
157. Noll K, Wegmann B, Havemann K, Jaques G. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines. J Clin Endocrinol Metab. 81:1996;2653-2662.
158. Jones J I, Clemmons D R. Insulin-like growth factors and their binding proteins: Biological actions. Endocrinol Rev. 16:1995;3-34.
159. Ranke M B, Elmlinger M. Functional role of insulin-like growth factor binding proteins. Horm Res. 48:1997;9-15.
160. Li, W, Fawcett, J, Widmer, H, R, Fielder, P, J, Rabkin, R, Keller, G, A. Nuclear transport of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in opossum kidney cells. Endocrinology138:1763-1766.
161. Portera C A, Shinohara H, Mima T, Miller A, Tsan R, Mascarenhas D, Radinsky R. Targeting insulin-like growth-I-receptor (IGF-I-R) signaling in the therapy of colorectal carcinoma (CRC) liver metastasis. Proc Am Assoc Cancer Res. 40:1999;2252.
162. Cohen P, Lamson G, Okajima T, Rosenfeld R G. Transfection of the human insulin-like growth factor binding protein-3 gene into Balb/c fibroblasts inhibits cellular growth. Mol Endocrinol. 7:1993;380-386.
163. Lalou C, Lassarre C, Binoux M. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin. Endocrinology. 137:1996;3206-3212.
164. Zadeh S M, Binoux M. The 16-kDa proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 inhibits the mitogenic action of fibroblast growth factor on mouse fibroblasts with a targeted disruption of the type 1 IGF receptor gene. Endocrinology. 138:1997;3069-3072.
165. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol. 9:1995;361-367.
166. Oh Y, Müller H L, Pham H, Rosenfeld R G. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J Biol Chem. 268:1993;26045-26048.
167. Yamanaka Y, Fowlkes J, Wilson E, Rosenfeld R G, Oh Y. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to breast cancer cells: Kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology. 140:1999;1319-1328.
168. Rajah R, Valentis B, Cohen P. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death via a p53- and IGF-independent mechanism. J Biol Chem. 272:1997;12181-12188.
169. Gucev Z S, Oh Y, Kelley K M, Rosenfeld R G. Insulin-like growth factor binding protein 3 mediaties retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res. 56:1996;1545-1550.
170. Erondu N E, Dake B L, Moser D R, Lin M, Boes M, Bar R S. Regulation of endothelial IGFBP-3 synthesis and secretion by IGF-I and TGF-beta. Growth Regul. 6:1996;1-9.
171. Giuliano M, Lauricella M, Vassallo E, Carabillo, Vento R, Tesoriere G. Induction of apoptosis in retinoblastoma cells by topoisomerase inhibitors. Invest Opthalmol Vis Sci. 39:1998;1300-1311.
172. Shen L, Dean N, Glazer R. Induction of p53-dependent, insulin-like growth factor-binding protein-3-mediated apoptosis in glioblastoma multiforme cells by a protein kinase C-alpha antisense oligonucleotide. Mol Pharmacol. 55:1999;396-402.
173. Schedlich L J, Young T F, Firth S M, Baxter R C. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells. J Biol Chem. 273:1998;18347-18352.
174. Wraight C J, Liepe I J, Werther G A. Intranuclear localization of insulin-like growth factor binding protein-3 during cell division in human keratinocytes. J Invest Dermatol. 111:1998;239-242.
175. Jaques G, Noll K, Wegmann B, Witten S, Kogan E, Radulescu R T, Havemann K. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line. Endocrinology. 138:1997;1767-1770.
176. Hodgkinson S, Fowke P, Al Somai N, McQuoid M. Proteins in tissue extracts which bind insulin-like growth factor binding protein-3 (IGFBP-3). J Endocrinol. 145:1995;R1-R6.
177. Yang Y W-H, Yanagishita M, Rechler M M. Heparin inhibition of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human fibroblasts and rat glioma cells: Role of heparan sulfate proteoglycans. Endocrinology. 137:1996;4363-4371.
178. Xu, W, Murphy, L, J, Interaction of IGFBP-3 with latent transforming growth factor-β binding protein-1 identified using the yeast two-hybrid system. In, Program & Abstracts of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, Bethesda, The Endocrine Society, p, 313, 1998.
179. Liu, B, R, Kurie, J, Lee, K, Clifford, J, Cohen, P, Interaction of insulin-like growth factor binding protein-3 and retinoid X receptor. In, Programs & Abstracts of the 81st Annual Meeting of the Endocrine Society, San Diego, CA, Bethesda, The Endocrine Society, 1999.
180. Collett-Solberg P F, Nunn S E, Beers Gibson T, Cohen P. Identification of novel high molecular weight insulin-like growth factor-binding protein-3 association proteins in human serum. J Clin Endocrinol Metab. 83:1998;2843-2848.
181. Cohen, P, Cell regulatory functions of IGFBP-3. In, Program & Abstracts of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, Bethesda, The Endocrine Society, p, 32, 1998.
182. Liu, B, R, Beers Gibson, T, Collett-Solberg, P, F, Zhao, H, Cerri, R, Mascarhenas, D, Cohen, P, Type I Collagen is an IGFBP-3 binding protein. In, Programs & Abstracts of the 81st Annual Meeting of the Endocrine Society, San Diego, CA, Bethesda, The Endocrine Society, p, 405, 1999.
183. Weinzimer, S, A, Beers Gibson, T, Collett-Solberg, Zhao, H, Liu, B, R, Khare, A, Cohen, P, Transferrin is an IGFBP-3 binding protein. In, Programs & Abstracts of the 81st Annual Meeting of the Endocrine Society, San Diego CA, Bethesda, The Endocrine Society, p, 83, 1999.
184. Leal S M, Liu Q, Huang S S, Huang J S. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein-3 receptor. J Biol Chem. 272:1997;20572-20576.
185. Schenker T, Trueb B. Down-regulated proteins of mesenchymal tumor cells. Exp Cell Res. 239:1998;161-168.
186. Reeve J G, Guadano A, Xiong J, Morgan J, Bleehen N M. Diminished expression of insulin-like growth factor (IGF) binding protein-5 and activation of IGF-I-mediated autocrine growth in simian virus 40-transformed human fibroblasts. J Biol Chem. 270:1995;135-142.
187. Cohen, P, Cell regulatory functions of IGFBP-3. In, Program & Abstracts of the 80th Annual Meeting of The Endocrine Society, New Orleans, LA, Bethesda, The Endocrine Society, p, 32, 1998.
188. Spencer E M, Chan K. A 3-dimensional model for the insulin-like growth factor binding proteins (IGFBPs); supporting evidence using the structural determinants of the IGF binding site on IGFBP-3. Prog Growth Factor Res. 6:1995;209-214.
189. Hashimoto R, Ono M, Fujiwara H, Higashihashi N, Yoshida M, Enjoh-Kimura T, Sakano K. Binding sites and binding properties of binary and ternary complexes of insulin-like growth factor-II (IGF-II), IGF-binding protein-3, and acid-labile subunit. J Biol Chem. 272:1997;27936-27942.
190. Firth S M, Ganeshprasad U, Baxter R C. Structural determinants of ligand and cell-surface binding of insulin-like-growth factor-binding protein-3. J Biol Chem. 273:1998;2631-2638.
191. Gucev Z S, Oh Y, Kelley K M, Rosenfeld R G. Insulin-like growth factor binding protein-3 mediates retinoic acid-and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res. 56:1996;1545-1550.
192. Werner H, Karnieli E, Rauscher F J, LeRoith D. Wild-type and mutant p53 differentially regulate transcription of the insulin-like growth factor I receptor gene. Proc Natl Acad Sci USA. 93:1996;8318-8323.
193. Nunn S E, Gibson T B, Rajah R, Cohen P. Regulation of prostate cell growth by the insulin-like growth factor binding proteins and their proteases. Endocrine. 7:1997;115-118.
194. Cohen P, Peehl D M, Stamey T A, Wilson K F, Clemmons D R, Rosenfeld R G. Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab. 76:1993;1031-1035.
195. Chatterjee, S, Dai, B, Owlia, A, Singh, P, Novel Strayegy for growth inhibition of human prostatic cancer cells: Endogenous insulin-like growth factor binding protein-2 (IGFBP-2) suppression. In, Programs & Abstracts of the 81st Annual Meeting of the Endocrine Society, San Diego, CA, Bethesda, The Endocrine Society, p, 169, 1999.
196. Wex H, Vorwerk P, Mohnike K, Bretschneider D, Kluba U, Aumann V, Blum W F, Mittler U. Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBP-2 mRNA in the tumour clone. Br J Cancer. 78:1998;515-520.
197. Petridou E, Dessypris N, Spanos E, Mantzoros C, Skalkidou A, Kalmanti M, Koliouskas D, Kosmidis H, Panagioutu J P, Piperopoulou F, Tzortzatou F, Trichopoulos D. Insulin-like growth factor-1 and binding protein-3 in relation to childhood leukaemia. Int J Cancer. 80:1999;494-496.
198. Wolk A, Mantzoros C S, Anderson S-O, Bergstrom R, Signorello L B, Lagiou P, Adami H-O, Dimitrios R. Insulin-like growth factor-I and prostate cancer risk: A population-based, case-control study. J Natl Cancer Inst. 90:1998;911-915.
199. Chan J M, Stampfer M J, Giovannucci E, Gann P H, Ma J, Wilkinson P, Hennekens C H, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: A prospective study. Science. 279:1998;563-566.
200. Hankinson S E, Willett W C, Colditz G A, Hunter D J, Michaud D S, Deroo B, Rosner B, Speizer F E, Pollak M. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 351:1998;1393-1396.
201. Yu H, Spitz M R, Mistry J, Gu J, Hong W K, Wu X. Plasma levels of insulin-like growth factor-I and lung cancer risk: A case-control analysis. J Natl Cancer Inst. 91:1999;151-156.
202. Ma J, Pollak M N, Giovannucci E, Cahn J M, Tao Y, Hennekens C H, Stampfer M J. Prospective Study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 91:1999;620-625.
203. Hwa V, Oh Y, Rosenfeld R G. Insulin-like growth factor binding proteins: A proposed superfamily. Acta Paediatr Suppl. 428:1999;37-45.
204. Hwa, V, Oh, Y, Rosenfeld, R, G, Insulin-like growth factor binding protein (IGFBP) superfamily: Structure, function, and evolution. In, Programs & Abstracts of the 81st Annual Meeting of the Endocrine Society, San Diego, CA, Bethesda, The Endocrine Society, p, 407, 1999.
205. Oh Y, Nagalla S R, Yamanaka Y, Kim H-S, Wilson E, Rosenfeld R G. Synthesis and characterization of insulin-like growth factor binding protein (IGFBP-7). J Biol Chem. 271:1996;30322-30325.
206. Murphy M, Pykett M J, Harnish P, Zang K D, George D L. Identification and characterization of genes differentially expressed in meningiomas. Cell Growth Differ. 4:1993;715-722.
207. Yamauchi T, Umeda F, Masakado M, Isaji M, Mizushima S, Nawata H. Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cells. Biochem J. 303:1994;591-598.
208. Akaogi K, Okabe Y, Funahashi K, Yoshitake Y, Nishikawa K, Yasunitsu H, Umeda M, Miyazaki K. Cell adhesion activity of a 30-kDa major secreted protein from human bladder carcinoma cells. Biochem Biophys Res Commun. 198:1994;1046-1053.
209. Burger A M, Zhang X, Li H, Ostrowski J L, Beatty B, Venanzoni M, Papas T, Seth A. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with disease progression in breast carcinomas. Oncogene. 16:1998;2459-2467.
210. Kim H-S, Nagalla S R, Oh Y, Wilson E, Roberts C T Jr, Rosenfeld R G. Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): Characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci USA. 94:1997;12981-12986.
211. Bradham D M, Igarashi A, Potter R L, Grotendorst G R. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol. 1114:1991;1285-1294.
212. Martinerie C, Viegas-Pequignot E, Guenard I, Dutrillaux B, Nguyen V, Bernheim A, Perbal B. Physical mapping of human loci homologous to the chicken nov proto-oncogene. Oncogene. 7:1992;2529-2534.
213. Jay P, Berge-Lefranc J, Marsollier C, Mejean C, Taviaux S, Berta P. The human growth factor-inducible immediate early gene, CYR61, maps to chromosome 1p. Oncogene. 14:1997;1753-1757.
214. Zumbrunn J, Trueb B. Primary structure of a putative serine protease specific for IGF-binding proteins. FEBS Lett. 398:1996;187-192.
215. Lassalle P, Molet S, Janin A, Heyden JV d, Tavernier J, Fiers W, Devos R, Tonnel A-B. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J Biol Chem. 271:1996;20458-20464.
216. Yamanaka Y, Wilson E M, Rosenfeld R G, Oh Y. Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem. 272:1997;30729-30734.
217. Vorwerk P, Yamanaka Y, Spagnoli A, Oh Y, Rosenfeld R G. Insulin and IGF binding by IGFBP-3 fragments derived from proteolysis, baculovirus expression and normal human urine. J Clin Endocrinol. 83:1998;1392-1395.
218. Pereira R, Blanquaert F, Canalis E. Cortisol enhances the expression of mac25/insulin-like growth factor-binding protein-related protein-1 in cultured osteoblasts. Endocrinology. 140:1999;228-232.
219. Pereira R, Canalis E. Parathyroid hormone increases mac25/insulin-like growth factor-binding protein-related protein-1 expression in cultured osteoblasts. Endocrinology. 140:1999;1998-2003.
220. Wilson E M, Oh Y, Rosenfeld R G. Generation and characterization of an IGFBP-7 antibody: Identification of 31kD IGFBP-7 in human biological fluids and Hs578T human breast cancer conditioned media. J Clin Endocrinol Metab. 82:1997;1301-1303.
221. Hwa, V, Oh, Y, Burren, C, P, Choi, W, K, Graham, D, L, Ingermann, A, Kim, H-S, Lopez Bermejo, A, Minniti, G, Pai, K, Spagnoli, A, Vorwerk, P, LV, Wanek, D, Wilson, E, M, Yamanaka, Y, Yang, D, Y, Rosenfeld, R, G. IGFBP Superfamily. In Proceedings of the 4th Annual DSL International Scientific Meeting (Rosenfeld, R, G, Lee, P, DK, Eds). Webster, TX, DSL Press, pp 142-153, 1998.
222. Wilson, H, MP, Birnbaum, R, S, Poot, M, Swisshelm: Introduction of IGFBP-rP1/mac25 into MCF-7 breast cancer cells induces growth inhibition and senescent morphology. In, Programs & Abstracts of the 81st Annual Meeting of the Endocrine Society, San Diego, CA, Bethesda, The Endocrine Society, p, 82, 1999.
223. Hwa V, Tomasini-sprenger C, Lopez Bermejo A, Rosenfeld R G, Plymate S R. Characterization of insulin-like growth factor-binding protein-related protein-1 in prostate cells. J Clin Endocrinol Metab. 83:1998;4355-4362.
224. Damon S E, Haugk K L, Swisshelm K, Quinn L S. Developmental regulation of Mac25/insulin-like growth factor-binding protein-7 expression in skeletal myogenesis. Exp Cell Res. 237:1997;192-195.
225. Wilson, E, M, Oh, Y, Hwa, V, Rosenfeld, R, G, Cloning and characterization of the IGFBP-rP1 interacting protein. In, Programs & Abstracts of the 81st Annual Meeting of the Endocrine Society, San Diego, CA, Bethesda, The Endocrine Society, p, 407, 1999.
226. Yang D H, Kim H-S, Wilson E M, Rosenfeld R G, Oh Y. Identification of glycosylated 38-kDa connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human breast cancer cells. J Clin Endocrinol Metab. 83:1998;2593-2596.
227. Vorwerk, P, Elsner, J, Oh, Y, Rosenfeld, R, G, Mittler, U, Insulin-like growth factor binding protein related protein-2 (IGFBP-rP2) in serum of patients with childhood acute lymphoblastix leukemia. In, Programs & Abstracts of the 81st Annual Meeting of the Endocrine Society, San Diego, CA, Bethesda, The Endocrine Society, p, 176, 1999.
228. Chevalier G, Yeger H, Martinerie C, Laurent M, Alami J, Schofield P N, Perbal B. novH. Differential expression in developing kidney and Wilm's tumors. Am J Pathol. 152:1998;1563-1575.
229. Perbal B, Martinerie C, Sainson R, Werner M, He B, Roizman B. The C-terminal domain of the regulatory protein NOVH is sufficient to promote interaction with fibulin 1C: A clue for a role of NOVH in cell-adhesion signaling. Proc Natl Acad Sci USA. 96:1999;869-874.
230. Burren C P, Wilson E M, Hwa V, Oh Y, Rosenfeld R G. Binding properties and distribution of insulin-like growth factor binding protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP superfamily. J Clin Endocrinol Metab. 84:1999;1096-1103.
231. Yang G P, Lau L F. Cell Growth Differ. 2:1991;351-357.
232. Babic A M, Kireeva M L, Kolenikova T V, Lau L F. CYR61, a product of a growth factor inducible immediate early gene, promotes angiogenesis and tumor growth. Proc Natl Acad Sci USA. 95:1998;6355-6360.
233. Pilarsky C P, Schmidt U, Eifsrich C, Stade J, Froschermaier S E, Haase M, Faller G, Kirchner T W, Wirth M P. Expression of the extracellular matrix signaling molecule Cyr 61 is downregulated in prostate cancer. Prostate. 36:1998;85-91.
234. Mathew S, Murty V V, Bosl G J, Chaganti R S. Loss of heterozygosity identifies multiple sites of allelic deletions on chromosome 1 in human male germ cell tumors. Cancer Res. 54:1994;6265-6269.
235. Lee W C, Balsara B, Liu Z, Jhanwar S C, Testa J R. Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res. 64:1996;42297-42301.